First off, thank you for your continued support and advice. I have incorporated most all of the points you have shared, over time.
Most recently, (6 weeks ago, I stopped taking AI due to Gene pointing out I was entering the danger zone with tanking E2. (6) weeks later my E2 has rebounded significantly.
Also, I'm really starting to feel good. I started TRT this past January and have been working to get into the groove every since. I can feel it..... I'm getting closer!
In addition, I started taking a new multi-vitamin that a few of the Excel male team recommended and I have experienced some improvements over the brand I was taking. Now using "Orange Triad". I had been fighting bloat and once I switched, the bloat was gone in a few days! I didn't see that one coming....
- I've posted my last two blood work profiles for referencing. The latest is on top. These tests are (6) weeks a part. It has been (12) weeks since my last pellet insertion.
- I Re-started AI today, .25 mg every 3rd day. This has been the very hardest to control. Either I'm too high or too low. Please offer some insight & advice.
- 1st pellet cycle was (20) weeks and was too long. (felt terrible at the end)
- 2nd cycle is complete in (2) weeks and that will have been (14) weeks since the 2nd insertion. The blood work below reflects my latest levels, in prep for the insertion.
The 2nd set of tests below reflects my levels, (6) into the 2nd cycle. Test results were very high. I actually was not feeling all that great. Gene suggested that due to my hper-physiological state, I should consider a dosage adjustment.
This cycle, my doctor plans to adjust the dose down from 2000 MG to 1600 MG (I'm nervous about that). (each pellet is 200 mg).
I'm starting to feel good!
Current Profile:
55 years old
Just re-strated AI - .25 mg every 3rd day (need doseage advice. EOD is too much)
6' tall
215 lbs (decent muscle mass for an older guy)
_Lab Receipt: 8/19/2014 5:29:00 PM Collection: 8/19/2014 3:46:00 PM Results: 8/22/2014 6:05:00 PM
[TH="width: 35%"]Description[/TH] | |||||
[TD="colspan: 5"][/TD] | |||||
[TD="colspan: 6, align: left"]005009 - CBC With Differential/Platelet[/TD] | |||||
WBC | 11.1 | x10E3/uL | 3.4-10.8 | F | |
RBC | 5.06 | x10E6/uL | 4.14-5.80 | F | |
Hemoglobin | 16.2 | g/dL | 12.6-17.7 | F | |
Hematocrit | 44.7 | % | 37.5-51.0 | F | |
MCV | 88 | fL | 79-97 | F | |
MCH | 32.0 | pg | 26.6-33.0 | F | |
MCHC | 36.2 | g/dL | 31.5-35.7 | F | |
RDW | 13.2 | % | 12.3-15.4 | F | |
Platelets | 290 | x10E3/uL | 150-379 | F | |
Neutrophils | 63 | % | 40-74 | F | |
Lymphs | 26 | % | 14-46 | F | |
Monocytes | 8 | % | 4-12 | F | |
Eos | 2 | % | 0-5 | F | |
Basos | 1 | % | 0-3 | F | |
Immature Cells | X | ||||
Neutrophils (Absolute) | 7.0 | x10E3/uL | 1.4-7.0 | F | |
Lymphs (Absolute) | 2.9 | x10E3/uL | 0.7-3.1 | F | |
Monocytes(Absolute) | 0.9 | x10E3/uL | 0.1-0.9 | F | |
Eos (Absolute) | 0.2 | x10E3/uL | 0.0-0.4 | F | |
Baso (Absolute) | 0.1 | x10E3/uL | 0.0-0.2 | F | |
Immature Granulocytes | 0 | % | 0-2 | F | |
Immature Grans (Abs) | 0.0 | x10E3/uL | 0.0-0.1 | F | |
NRBC | X | ||||
Hematology Comments: | X | ||||
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]322000 - Comp. Metabolic Panel (14)[/TD] | |||||
Glucose, Serum | 91 | mg/dL | 65-99 | F | |
BUN | 13 | mg/dL | 6-24 | F | |
Creatinine, Serum | 1.25 | mg/dL | 0.76-1.27 | F | |
eGFR If NonAfricn Am | 65 | mL/min/1.73 | >59 | F | |
eGFR If Africn Am | 75 | mL/min/1.73 | >59 | F | |
BUN/Creatinine Ratio | 10 | 9-20 | F | ||
Sodium, Serum | 138 | mmol/L | 134-144 | F | |
Potassium, Serum | 3.5 | mmol/L | 3.5-5.2 | F | |
Chloride, Serum | 95 | mmol/L | 97-108 | F | |
Carbon Dioxide, Total | 27 | mmol/L | 18-29 | F | |
Calcium, Serum | 9.4 | mg/dL | 8.7-10.2 | F | |
Protein, Total, Serum | 6.7 | g/dL | 6.0-8.5 | F | |
Albumin, Serum | 4.4 | g/dL | 3.5-5.5 | F | |
Globulin, Total | 2.3 | g/dL | 1.5-4.5 | F | |
A/G Ratio | 1.9 | 1.1-2.5 | F | ||
Bilirubin, Total | 0.5 | mg/dL | 0.0-1.2 | F | |
Alkaline Phosphatase, S | 66 | IU/L | 39-117 | F | |
AST (SGOT) | 29 | IU/L | 0-40 | F | |
ALT (SGPT) | 24 | IU/L | 0-44 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]140103 - Testosterone,Free and Total[/TD] | |||||
Testosterone, Serum | 1371 | ng/dL | 348-1197 | F | |
Comment: | F | ||||
[TD="colspan: 6"] | Adult male reference interval is based on a population of lean males[/TD] | ||||
[TD="colspan: 6"] | up to 40 years old.[/TD] | ||||
Free Testosterone(Direct) | 30.4 | pg/mL | 7.2-24.0 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]004283 - Luteinizing Hormone(LH), S[/TD] | |||||
LH | 0.1 | mIU/mL | 1.7-8.6 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]004309 - FSH, Serum[/TD] | |||||
FSH | <0.2 | mIU/mL | 1.5-12.4 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]004515 - Estradiol[/TD] | |||||
Estradiol | 75.6 | pg/mL | 7.6-42.6 | F | |
[TD="colspan: 6"] | Roche ECLIA methodology[/TD] | ||||
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]010322 - Prostate-Specific Ag, Serum[/TD] | |||||
Prostate Specific Ag, Serum | 1.6 | ng/mL | 0.0-4.0 | F | |
[TD="colspan: 6"] | Roche ECLIA methodology.[/TD] | ||||
[TD="colspan: 6"] | .[/TD] | ||||
[TD="colspan: 6"] | According to the American Urological Association, Serum PSA should[/TD] | ||||
[TD="colspan: 6"] | decrease and remain at undetectable levels after radical[/TD] | ||||
[TD="colspan: 6"] | prostatectomy. The AUA defines biochemical recurrence as an initial[/TD] | ||||
[TD="colspan: 6"] | PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory[/TD] | ||||
[TD="colspan: 6"] | PSA value 0.2 ng/mL or greater.[/TD] | ||||
[TD="colspan: 6"] | Values obtained with different assay methods or kits cannot be used[/TD] | ||||
[TD="colspan: 6"] | interchangeably. Results cannot be interpreted as absolute evidence[/TD] | ||||
[TD="colspan: 6"] | of the presence or absence of malignant disease.[/TD] | ||||
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]140244 - Estradiol, Sensitive[/TD] | |||||
Estradiol, Sensitive | 94 | pg/mL | 3-70 | F | |
[TD="colspan: 6"] | Male Female[/TD] | ||||
[TD="colspan: 6"] | 0- 6 yrs. 0 - 15 0 - 15[/TD] | ||||
[TD="colspan: 6"] | 7-10 yrs. 0 - 15 0 - 70[/TD] | ||||
[TD="colspan: 6"] | 11-12 yrs. 0 - 40 10 - 300[/TD] | ||||
[TD="colspan: 6"] | 13-15 yrs. 0 - 45 10 - 300[/TD] | ||||
[TD="colspan: 6"] | >15 yrs. 3 - 70 See Below[/TD] | ||||
[TD="colspan: 6"] | Ovulating Female[/TD] | ||||
[TD="colspan: 6"] | Follicular Phase 9 - 175[/TD] | ||||
[TD="colspan: 6"] | Luteal Phase 44 - 196[/TD] | ||||
[TD="colspan: 6"] | Periovulatory 107 - 281[/TD] | ||||
[TD="colspan: 6"] | Oral Contraceptives 0 - 91[/TD] | ||||
[TD="colspan: 6"] | Postmenopausal[/TD] | ||||
[TD="colspan: 6"] | Treated 42 - 289[/TD] | ||||
[TD="colspan: 6"] | Untreated 0 - 19[/TD] |
______________________________________________________________________________
6 weeks ago
Lab Receipt: 7/7/2014 12:47:00 PM Collection: 7/7/2014 7:37:00 AM Results: 7/9/2014 6:05:00 PM
[TH="width: 35%"]Description[/TH] | |||||
[TD="colspan: 5"][/TD] | |||||
[TD="colspan: 6"] | Patient is Fasting[/TD] | ||||
[TD="colspan: 6, align: left"]005009 - CBC With Differential/Platelet[/TD] | |||||
WBC | 6.8 | x10E3/uL | 3.4-10.8 | F | |
RBC | 4.88 | x10E6/uL | 4.14-5.80 | F | |
Hemoglobin | 15.2 | g/dL | 12.6-17.7 | F | |
Hematocrit | 44.2 | % | 37.5-51.0 | F | |
MCV | 91 | fL | 79-97 | F | |
MCH | 31.1 | pg | 26.6-33.0 | F | |
MCHC | 34.4 | g/dL | 31.5-35.7 | F | |
RDW | 13.6 | % | 12.3-15.4 | F | |
Platelets | 268 | x10E3/uL | 150-379 | F | |
Neutrophils | 54 | % | 40-74 | F | |
Lymphs | 32 | % | 14-46 | F | |
Monocytes | 9 | % | 4-12 | F | |
Eos | 4 | % | 0-5 | F | |
Basos | 1 | % | 0-3 | F | |
Immature Cells | X | ||||
Neutrophils (Absolute) | 3.6 | x10E3/uL | 1.4-7.0 | F | |
Lymphs (Absolute) | 2.1 | x10E3/uL | 0.7-3.1 | F | |
Monocytes(Absolute) | 0.6 | x10E3/uL | 0.1-0.9 | F | |
Eos (Absolute) | 0.3 | x10E3/uL | 0.0-0.4 | F | |
Baso (Absolute) | 0.1 | x10E3/uL | 0.0-0.2 | F | |
Immature Granulocytes | 0 | % | 0-2 | F | |
Immature Grans (Abs) | 0.0 | x10E3/uL | 0.0-0.1 | F | |
NRBC | X | ||||
Hematology Comments: | X | ||||
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]322000 - Comp. Metabolic Panel (14)[/TD] | |||||
Glucose, Serum | 104 | mg/dL | 65-99 | F | |
BUN | 19 | mg/dL | 6-24 | F | |
Creatinine, Serum | 1.32 | mg/dL | 0.76-1.27 | F | |
eGFR If NonAfricn Am | 61 | mL/min/1.73 | >59 | F | |
eGFR If Africn Am | 70 | mL/min/1.73 | >59 | F | |
BUN/Creatinine Ratio | 14 | 9-20 | F | ||
Sodium, Serum | 141 | mmol/L | 134-144 | F | |
Potassium, Serum | 4.2 | mmol/L | 3.5-5.2 | F | |
Chloride, Serum | 100 | mmol/L | 97-108 | F | |
Carbon Dioxide, Total | 28 | mmol/L | 18-29 | F | |
Calcium, Serum | 9.2 | mg/dL | 8.7-10.2 | F | |
Protein, Total, Serum | 6.2 | g/dL | 6.0-8.5 | F | |
Albumin, Serum | 4.3 | g/dL | 3.5-5.5 | F | |
Globulin, Total | 1.9 | g/dL | 1.5-4.5 | F | |
A/G Ratio | 2.3 | 1.1-2.5 | F | ||
Bilirubin, Total | 0.3 | mg/dL | 0.0-1.2 | F | |
Alkaline Phosphatase, S | 68 | IU/L | 39-117 | F | |
AST (SGOT) | 29 | IU/L | 0-40 | F | |
ALT (SGPT) | 23 | IU/L | 0-44 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]140103 - Testosterone,Free and Total[/TD] | |||||
Testosterone, Serum | 1327 | ng/dL | 348-1197 | F | |
Comment: | F | ||||
[TD="colspan: 6"] | Adult male reference interval is based on a population of lean males[/TD] | ||||
[TD="colspan: 6"] | up to 40 years old.[/TD] | ||||
Free Testosterone(Direct) | 41.8 | pg/mL | 7.2-24.0 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]004283 - Luteinizing Hormone(LH), S[/TD] | |||||
LH | 0.1 | mIU/mL | 1.7-8.6 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]004309 - FSH, Serum[/TD] | |||||
FSH | 0.3 | mIU/mL | 1.5-12.4 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]004515 - Estradiol[/TD] | |||||
Estradiol | 17.7 | pg/mL | 7.6-42.6 | F | |
[TD="colspan: 6"] | Roche ECLIA methodology[/TD] | ||||
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]010322 - Prostate-Specific Ag, Serum[/TD] | |||||
Prostate Specific Ag, Serum | 1.7 | ng/mL | 0.0-4.0 | F |